CELC celcuity.com: Rasio total nilai perusahaan marang pendapatan

celcuity.com (CELC) - logo korporat

A high concentration on cellular platforms creates risks, which are clearly demonstrated by the company's price-to-sales ratio. However, the 0.00 mark characterizes this parameter within the context of the Celcuity Inc. (CELC) CEL-signia precision oncology strategy for therapy selection. The advantage of live-cell analysis allows for premium pricing, which, combined with the development of proprietary drugs, ensures the fundamental stability of the business.

Multiplikator EV/Sales Celcuity (CELC): kanggo periode 23.11.2025 - 20.11.2026

Celcuity Therapeutics - rincian analitis lan metrik utama (CELC)

- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:CELC - Celcuity Inc.
Barang unggulan Celcuity Corp

To objectively analyze asset quality, one should evaluate the business's enterprise value excluding debt, which helps identify unjustified price growth. The EV-to-revenue trend demonstrates the real price of one dollar of revenue, helping investors timely recognize speculative valuation overheating for Celcuity Inc. (CELC) amid the scaling of its diagnostic alliances with pharma behemoths.